LUMIERA HEALTH INNOVATION
Dead / Abandoned — Abandoned — failure to respond (as of 24 Aug 2022)
What this means for you
This application is over — abandoned 02 Aug 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88910691
- Mark type
- Stylized text
- Filed
- 11 May 2020
- Abandoned
- 02 Aug 2022
- Attorney of record
- Shamus T. O'Doherty
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of pain and inflammation; pharmaceutical preparations for the treatment of ocular pain and inflammation, uveitis and dried eyes in humans; pharmaceutical preparations for the treatment of ocular pain and inflammation, uveitis and dried eyes in pets; pharmaceutical preparations for the treatment of cold sores; pharmaceutical preparations for the treatment of interstitial cystitis in humans
Owner
- TETRA BIO-PHARMA INC., Longueuil, Quebec, CA
Prosecution history
- 24 Aug 2022 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 24 Aug 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 31 Jan 2022 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
- 31 Jan 2022 — INQUIRY TO SUSPENSION E-MAILED
- 31 Jan 2022 — SUSPENSION INQUIRY WRITTEN
- 31 Jan 2022 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 28 Jan 2022 — ASSIGNED TO EXAMINER
- 30 Jul 2021 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 15 Oct 2020 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 15 Oct 2020 — LETTER OF SUSPENSION E-MAILED
- 15 Oct 2020 — SUSPENSION LETTER WRITTEN
- 14 Oct 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Oct 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Oct 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Aug 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED